My Account Log in

3 options

Estrogen prevention for breast cancer / Zsuzsanna Suba, editor.

EBSCOhost Academic eBook Collection (North America) Available online

View online

EBSCOhost Ebook Medical Collection Available online

View online

Ebook Central Academic Complete Available online

View online
Format:
Book
Contributor:
Suba, Zsuzsanna.
Series:
Cancer etiology, diagnosis, and treatments.
Cancer etiology, diagnosis and treatments
Language:
English
Subjects (All):
Cancer--Hormone therapy.
Cancer.
Estrogen.
Breast--Cancer.
Breast.
Physical Description:
1 online resource (170 p.)
Edition:
1st ed.
Place of Publication:
New York : Nova Science Publishers, 2013.
Language Note:
English
Summary:
From the early 80s of the past century, clinical and epidemiological studies have increasingly pointed to an elevated breast, endometrial and ovarian cancer risk from high circulating estrogen levels. Estrogen deficiency as a cancer risk factor emerged first in 2007 in a study on Hungarian oral cancer cases based on the gender and age- related differences in tumor prevalence. Critical reevaluation of the contradictory results of hormone replacement therapy yielded a complete conversion that estrogen deficiency may confer cancer initiation. This book examines the deleterious interactions between estrogen deficiency and further hormonal disorders which illuminate the apparently controversial associations of obesity, light exposure and alcohol intake with breast cancer risk.
Contents:
Intro
ESTROGEN PREVENTION FOR BREAST CANCER
Library of Congress Cataloging-in-Publication Data
Contents
Preface
Acknowledgements
Chapter I: Discovery of Estrogen Deficiency as Common Cancer Risk Factor for Highly and Moderately Estrogen Dependent Organs
Abstract
Introduction
Risk Factors for Cancers of Highly Hormone Related Organs
Controversial Associations of Hormone Replacement Therapy and Cancer Risk
Shortcomings of Studies on the Correlations between HRT Use and Cancer Risk
Estrogen Deficiency and Cancer Risk in Postmenopausal Women
Moderate Estrogen Deficiency and Cancer Risk in Premenopausal Women
Conspicuous Differences between Cancer Epidemiology of Highly and Moderately Estrogen Dependent Organs
Extraovarian Estrogen Synthesis
Estrogen Deficiency in Men
Conclusion
References
Chapter II: Interaction between Insulin and Estrogen in the Regulation of Cell Proliferation and Carcinogenesis
Correlations between Insulin Resistance and Cancer Risk
Historical Review of Associations between Estrogen and Cancer Development
Molecular Mechanism of Interplay between the Actions of Estrogen and Insulin
Clinical Correlations between Estrogen Deficiency, Insulin Resistance and Cancer Risk
Chapter III: Dose Dependent Biphasic Effect of Alcohol on Estrogen Level and Cancer Risk
Ambiguous Biphasic Metabolic and Hormonal Effects of Moderate and Excessive Alcohol Consumption
Associations of Alcohol Consumption, Estrogen Level and Breast Cancer Risk
Alcohol Consumption, Hormonal Changes and Risk for Oral Cancer
Chapter IV: Estrogen Level May Be Protective for Breast Cancer in Obese Women
Introduction.
Grade and Distribution of Fat Deposition and Breast Cancer Risk
Age-Related Role of Obesity in the Prediction of Breast Cancer Risk
Effects of Reproductive Data and Menstrual Factors on Obesity-Associated Breast Cancer Risk
Effects of Exogenous Hormone Treatment on Breast Cancer Risk
Obesity Related Metabolic and Hormonal Disorders as Mediators of Breast Cancer Risk
Counteraction between Obesity Associated Insulin Resistance and Protective Circulatory Estrogen Level
Chapter V: Newly Recognized Player in Breast Cancer Risk: Light Deficiency
Differences in Breast Cancer Incidence and Mortality between African-American and White American Women
Excessive Cancer Risk of African-Americans and Dark Skinned Immigrants in Northern Geographic Regions
Traditional Concept Concerning the Oncostatic Capacity of Melatonin Hormone
Correlations between Excessive Melatonin Level, Other Endocrine Functions and Cancer Risk
Correlations among Light Exposure, Melatonin Level and Breast Cancer Risk
Chapter VI: Estrogen Prevention of Breast Cancer: A Critical Review
Background: Randomized HRT WHI Trials
Critique of the WHI HRT Trial Reporting
Estrogen and the Rates of Invasive Breast Cancer
Estrogen Benefit in Human Breast Cancer - Clinical Stage IV Breast Cancer
Estrogen Benefit in Breast Cancer: Basic Research Data and Mechanism of Action
Estrogen in Prevention of Breast Cancer? The Final 2000 - 2012 Reports
Chapter VII: Failures and Controversies of the Antiestrogen Treatment of Breast Cancer
Molecular Mechanisms of Estrogen Action
Estrogen Receptors and Their Actions.
Interplay between Alpha and Beta Estrogen Receptor Isoforms in the Regulation of Cell Proliferation and of Apoptotic Cell Death
Cross Talk between Receptor Signals of Estrogen and Growth Factors
Estrogen Receptors and Human Cancers
Estrogen Synthesis in Tumors
Antiestrogen and Estrogen in Cancer Therapy
Chapter VIII: Evolution of Estrogen Action in Breast Cancer: From Culprit to Killer
Evolution of Fashions in Breast Cancer Treatment and Prevention
Selective ER Modulation: Translation from the Laboratory to Clinical Practice
A Roadmap to Use SERMS to Prevent Multiple Diseases in Women
Raloxifene in Clinical Practice
Summary of SERMs
The Evolution of Acquired Resistance to Antihormonal Therapies
Molecular Mechanisms of the Apoptotic Action of Estrogens
Clinical Significance of Estrogen Induced Apoptosis
Acknowledgments
Index.
Notes:
"Nova biomedical."
Includes bibliographical references and index.
Description based on print version record.
ISBN:
1-62417-393-4
OCLC:
839699426

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account